Clinic of Plastic, Reconstructive, Hand and Burn Surgery, Hospital Cologne Merheim, University of Witten-Herdecke, 51109 Cologne, Germany.
Medicina (Kaunas). 2020 Dec 17;56(12):706. doi: 10.3390/medicina56120706.
The use of plant-based products for burn treatment dates back to 1600 BC. Enzymatic debridement, which can be achieved as non-surgical or conservative debridement, has recently gained increasing attention. Several reviews have been published thus far. However, there has been no historical article including the achievements of the last 20 years, and this is the first review to present the achievements made in the field of enzymatic debridement in the last 20 years. This study aimed to present a historical overview of the development of enzymatic debridement until the present day. : Enzymes from bacteria and plants were initially used for full-thickness burn treatment; however, they did not gain attention. Papain-derived products were the first plant-based products used for enzymatic debridement. Sutilains gained broad use in the 70s and 80s but came off market in the 1990s. Bromelain has been used for burn treatment owing to its strong debriding properties. NexoBrid is used as a minimally invasive approach for enzymatic debridement of deep dermal burns. However, its use has been limited due to commercially available bromelain and the presence of four distinct cysteine proteinases. NexoBrid involves faster eschar removal together with reduced blood loss, leading to improved long-term outcomes. However, research on nonoperative enzymatic debridement of burns has taken decades and is still ongoing. : Overall, the results of our study indicate that necrectomy, which has been used for a long time, remains the standard of care for burns. However, enzymatic debridement has several advantages, such as faster eschar removal, reduced blood loss, and reduced need for skin grafting, especially in cases of facial and hand burns. Enzymatic debridement cannot replace surgical intervention, as the enzyme only works on the surface of the eschar. Enzymatic debridement is not recommended in the early phase of scald burns. : Enzymatic debridement has become an integral part of burn therapy and the standard of care in specific burn centers.
植物源产品在烧伤治疗中的应用可以追溯到公元前 1600 年。酶清创术,可通过非手术或保守清创术实现,最近受到越来越多的关注。迄今为止已经发表了几篇综述,但没有一篇包括过去 20 年成就的历史文章,这是第一篇综述介绍过去 20 年酶清创术领域的成就。本研究旨在对酶清创术的发展进行历史回顾,直至今日。
细菌和植物来源的酶最初用于全层烧伤治疗,但并未引起关注。木瓜蛋白酶衍生产品是第一个用于酶清创术的植物源性产品。丝氨酸蛋白酶在 70 年代和 80 年代广泛应用,但在 90 年代退出市场。由于具有较强的清创作用,菠萝蛋白酶被用于烧伤治疗。NexoBrid 被用作深度真皮烧伤的微创酶清创方法。然而,由于商业上可获得的菠萝蛋白酶和四种不同的半胱氨酸蛋白酶的存在,其使用受到限制。NexoBrid 可更快地去除焦痂,同时减少失血,从而改善长期结果。然而,非手术性烧伤酶清创的研究已经进行了几十年,仍在继续。
总的来说,我们的研究结果表明,长期以来一直用于治疗烧伤的切除术仍然是烧伤治疗的标准。然而,酶清创术具有许多优点,例如更快地去除焦痂、减少失血和减少植皮的需要,特别是在面部和手部烧伤的情况下。酶清创术不能替代手术干预,因为酶仅作用于焦痂的表面。在烫伤烧伤的早期阶段不建议进行酶清创术。
酶清创术已成为烧伤治疗的一个组成部分,在特定的烧伤中心已成为标准的治疗方法。